Import activity
What Hanpars brought into Iran in 2026: the overall value and quantity, and the molecules behind it.
Imports in 2026
- €33.4 M
- total value of imports, 2026
- 100.8 M
- units imported
- 30
- molecules imported
HANPARS began importing at the end of 2025 with two emergency products, misoprostol and naloxone. Through 2026 the portfolio has grown steadily as new IRC licences were granted, and the pace of imports accelerated markedly in the second half of the year.
In 2026 the company has imported more than 33 million euros’ worth of medicines — over 100 million units across 30 molecules, including contrast media, hormones, CNS medicines, anti-infectives and critical-care products — sourced from manufacturers in Türkiye, China and the United Kingdom. Further registered orders are scheduled for the coming months.
What we import — by molecule
Each bubble is one generic molecule imported in 2026. Bubble size reflects the relative import volume; colour is the therapeutic area. Hover or tap a bubble for its quantity.
- Hydrocortisone (as sodium succinate): 3.5 M units (Hormones & endocrinology)
- Clopidogrel (as bisulfate): 25.8 M units (Cardiovascular)
- Sertraline (as hydrochloride): 20.7 M units (CNS & psychiatry)
- Iodixanol: 181 k units (Contrast media)
- Iohexol: 330 k units (Contrast media)
- Cyproterone compound: 10.0 M units (Hormones & endocrinology)
- Olanzapine: 10.0 M units (CNS & psychiatry)
- Ampicillin: 1.2 M units (Anti-infectives)
- Calcitonin: 500 k units (Hormones & endocrinology)
- Estradiol valerate: 10.0 M units (Hormones & endocrinology)
- Infliximab: 15 k units (Immunology & oncology support)
- Hydroxychloroquine sulfate: 10.0 M units (Anti-infectives)
- Calcium folinate: 150 k units (Immunology & oncology support)
- Exemestane: 1.0 M units (Hormones & endocrinology)
- Meglumine compound: 70 k units (Contrast media)
- Lidocaine / chlorhexidine: 300 k units (Emergency & critical care)
- Cefuroxime (as axetil): 1.0 M units (Anti-infectives)
- Alendronate (as sodium): 1.0 M units (Other specialties)
- Naloxone hydrochloride: 700 k units (Emergency & critical care)
- Misoprostol: 1.0 M units (Other specialties)
- Etomidate: 70 k units (Emergency & critical care)
- Vancomycin (as hydrochloride): 200 k units (Anti-infectives)
- Heparin sodium: 47 k units (Emergency & critical care)
- Chloroquine phosphate: 300 k units (Anti-infectives)
- Aminophylline: 300 k units (Emergency & critical care)
- Rifampicin: 1.2 M units (Anti-infectives)
- Clozapine: 720 k units (CNS & psychiatry)
- Clomipramine hydrochloride: 360 k units (CNS & psychiatry)
- Ampicillin / sulbactam: 144 k units (Anti-infectives)
- Salbutamol (as sulfate): 15 k units (Emergency & critical care)
- Contrast media
- Hormones & endocrinology
- CNS & psychiatry
- Cardiovascular
- Anti-infectives
- Emergency & critical care
- Immunology & oncology support
- Other specialties
30 molecules and 100.8 million units imported in 2026. Hydrocortisone, clopidogrel and sertraline are the largest lines, and the contrast media together form the fastest-turning part of the portfolio.
Tell us the product and the market. We will tell you the next step.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.